Editorial Comment to Adrenal metastasis in nivolumab-treated renal cell carcinoma: A unique entity as a sanctuary site

Int J Urol. 2022 Jun;29(6):599. doi: 10.1111/iju.14868. Epub 2022 Apr 2.

Authors

Noriaki Lukas Santo¹, Nishimoto Koshiro²

Affiliations

¹ Clinical Research Center, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
² Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.

PMID: 35368122
DOI: 10.1111/iju.14868

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents, Immunological* / adverse effects
Carcinoma, Renal Cell* / drug therapy
Carcinoma, Renal Cell* / pathology
Humans
Kidney Neoplasms* / drug therapy
Kidney Neoplasms* / pathology
Nivolumab / therapeutic use

Substances

Antineoplastic Agents, Immunological
Nivolumab